perfosfamide has been researched along with Myelodysplastic Syndromes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambinder, RF; Blackford, AL; Davis-Sproul, JM; Gocke, CD; Gore, SD; Jones, RJ; Kasamon, YL; Seifter, EJ | 1 |
| Abels, J; Hagemeijer, A; Lindemans, J; Pegels, J; Schipperus, M; Sonneveld, P; Vink, N | 1 |
1 trial(s) available for perfosfamide and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Extended follow-up of autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide (4-HC) purging for indolent or transformed non-Hodgkin lymphomas.
Topics: Adult; Antineoplastic Agents; Bone Marrow Transplantation; Cell Transformation, Neoplastic; Cyclophosphamide; Female; Follow-Up Studies; Humans; Leukemia; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous | 2011 |
1 other study(ies) available for perfosfamide and Myelodysplastic Syndromes
| Article | Year |
|---|---|
The effects of interleukin-3, GM-CSF, and G-CSF on the growth kinetics of colony-forming cells in myelodysplastic syndromes.
Topics: Bone Marrow; Bone Marrow Cells; Cell Cycle; Cell Division; Colony-Stimulating Factors; Culture Media; Cyclophosphamide; Giant Cell Tumors; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Growth Substances; Humans; Interleukin-3; Myelodysplastic Syndromes; Recombinant Proteins; Stem Cells; Tumor Cells, Cultured | 1990 |